3.29
전일 마감가:
$3.23
열려 있는:
$3.53
하루 거래량:
159.29K
Relative Volume:
0.63
시가총액:
$24.92M
수익:
-
순이익/손실:
$-72.26M
주가수익비율:
-1.5971
EPS:
-2.06
순현금흐름:
$-68.44M
1주 성능:
-9.86%
1개월 성능:
-39.63%
6개월 성능:
+171.90%
1년 성능:
+171.90%
레인 테라퓨틱스 Stock (RAIN) Company Profile
RAIN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RAIN
Rain Enhancement Technologies Holdco Inc
|
3.29 | 24.92M | 0 | -72.26M | -68.44M | -2.06 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
455.22 | 117.23B | 10.63B | -479.80M | -1.35B | -1.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
665.46 | 72.75B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
636.02 | 38.65B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.99 | 34.69B | 2.09B | -332.26M | 16.06M | -2.62 |
![]()
BNTX
Biontech Se Adr
|
114.50 | 27.45B | 3.30B | -501.07M | 1.03B | -2.1146 |
레인 테라퓨틱스 Stock (RAIN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-03-21 | 개시 | SVB Securities | Outperform |
2023-01-31 | 재개 | ROTH Capital | Buy |
2023-01-23 | 개시 | Mizuho | Buy |
2022-09-12 | 개시 | H.C. Wainwright | Buy |
2022-04-01 | 개시 | Oppenheimer | Outperform |
2021-09-14 | 재개 | Goldman | Neutral |
2021-07-20 | 개시 | Piper Sandler | Overweight |
2021-05-18 | 개시 | Citigroup | Buy |
2021-05-18 | 개시 | Goldman | Buy |
2021-05-18 | 개시 | Guggenheim | Buy |
2021-05-18 | 개시 | Piper Sandler | Overweight |
모두보기
레인 테라퓨틱스 주식(RAIN)의 최신 뉴스
Rain enhancement technologies' Paul Dacier buys $150,040 in stock - MSN
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Rain enhancement technologies' Paul Dacier buys $150,040 in stock By Investing.com - Investing.com Australia
Rain enhancement technologies’ Paul Dacier buys $150,040 in stock By Investing.com - Investing.com Nigeria
Rain Enhancement Technologies names new CEO to drive growth - MSN
Rain Enhancement Technologies Appoints Randall Seidl as Sole CEO -February 03, 2025 at 01:24 pm EST - Marketscreener.com
Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer - Business Wire
Personal Finance - Business Wire
UKG and Dell Technologies Launch Solar Community Hub in Mexico in Collaboration With Tecnológico de Monterrey and Computer Aid International - Quantisnow
Dell transforms AI PC portfolio for anywhere productivity - Quantisnow
Stock market today: NextNav -22.28%, Intrusion -19.76% among biggest losers in early trading - Business Upturn
Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn
Bad weather alert for Sabah, Sarawak and Labuan - The Malaysian Reserve
Stock market news: Dogness (International) -25.96%, Heartcore Enterprises -21.48% among biggest losers during mid day trading - Business Upturn
FTSE 100 Holds Steady as Energy Shares Offset Sectoral Declines – Market - HPBL
FTSE 100 Pauses After Weekly Surge Amid Energy Gains and Retail Challenges – Market - HPBL
FTSE 100 Rallies While NASDAQ 100 Wavers: A Tale of Two Indices – Market - HPBL
DAX Begins 2025 Strong: Can It Break the 20,523 Record High? – Market - HPBL
Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. But Geopolitical Uncertainty Could Slow M&A Growth in 2025 - Law.com International
Deal Watch: Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. Plus, Mixed Messages for 2025 M&A - Law.com
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn
Spain IBEX 35 Rises on Energy and Consumer Goods Gains, Gold and Oil Prices Surge – Market - HPBL
Fidelity MSCI Financials Index ETF (FNCL): A Cost-Effective Gateway to the Financial Sector – Market - HPBL
Fidelity Boosts Valuation of Elon Musk X by 32%, Signaling Renewed Optimism – Market - HPBL
JPMorgan Global Growth & Income Plc Issues 200,000 Shares, Raising Capital for Future Strategy - HPBL
Neumora Therapeutics and Other Stocks Suffer Major Losses as Market Faces Declines - HPBL
Rain Oncology, Alset Inc., and Other Stocks Surge as Investors Eye Market Opportunities - HPBL
Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL
Tech Stocks Display Mixed Performance in Early Market Trading: Tesla Drops While MicroStrategy Soars - HPBL
Trump Media & Technology Group (DJT) Sees Modest Stock Rise Amid Volatility – Market - HPBL
3 Vanguard ETF to Buy in 2025 for Higher Yields and Lower P/E Ratios Amid Market Volatility - HPBL
Stock market today: Neumora Therapeutics down by 81.14% while Rain Oncology surged by 676.86% in early trading - Business Upturn
Stock market today: Rain Oncology +603.31%, Alset +103.93% among top gainers in early trading - Business Upturn
Rain Enhancement Technologies Completes Business Combination with Coliseum Acquisition - Defense World
레인 테라퓨틱스 (RAIN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):